Benjamin Paluch

Stock Analyst at Roth MKM

(1.34)

# 3,597

Out of 4,989 analysts

3

Total ratings

33.33%

Success rate

0.8%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Benjamin Paluch

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CGON CG Oncology	Initiates: Buy	$65	$36.45	+78.33%	1	Aug 27, 2024
	REPL Replimune Group	Initiates: Buy	$17	$4.08	+316.67%	1	Aug 27, 2024
	GNLX Genelux	Initiates: Buy	$10	$4.19	+138.66%	1	Aug 27, 2024

CG Oncology

Aug 27, 2024

Initiates: Buy

Price Target: $65

Current: $36.45

Upside: +78.33%

Replimune Group

Aug 27, 2024

Initiates: Buy

Price Target: $17

Current: $4.08

Upside: +316.67%

Genelux

Aug 27, 2024

Initiates: Buy

Price Target: $10

Current: $4.19

Upside: +138.66%